Skip to main content
Log in

Ticagrelor not cost effective in East Asia

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2016 US dollars

Reference

  • Wu B, et al. Health Economic Analysis of Antiplatelet Therapy for Acute Coronary Syndromes in the Context of Five Eastern Asian Countries. Clinical Drug Investigation : 30 Apr 2018. Available from: URL: http://doi.org/10.1007/s40261-018-0649-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ticagrelor not cost effective in East Asia. PharmacoEcon Outcomes News 803, 25 (2018). https://doi.org/10.1007/s40274-018-4952-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4952-9

Navigation